On June 6, 2019, upon recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of Bionano Genomics, Inc. (the Company), the Company's Board of Directors (the Board) approved an increase in its authorized size from seven members to eight members and appointed Kristiina Vuori, M.D., effective as of June 6, 2019, to fill the vacancy created by such increase and serve as a Class II director until the Company's 2020 Annual Meeting of Stockholders.